This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Princeton University. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Philip A. Albiniak
Introduction
Philip A. Albiniak is an accomplished inventor based in Muncie, Indiana. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target cellular IAPs (inhibitor of apoptosis proteins). His work has implications for therapeutic and diagnostic applications.
Latest Patents
Albiniak holds a patent for IAP binding compounds. These compounds are designed to bind to cellular IAPs and are mimetics of the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABOLO, IIid, Grim, and Reaper. The patent outlines methods for using these compounds in therapeutic, diagnostic, and assay purposes.
Career Highlights
Albiniak is affiliated with Princeton University, where he continues to engage in innovative research. His work has garnered attention for its potential to advance understanding in the field of apoptosis and cellular regulation.
Collaborations
He has collaborated with notable colleagues, including George McLendon and Rachael A. Kipp, contributing to a dynamic research environment that fosters innovation.
Conclusion
Philip A. Albiniak's contributions to the field of biochemistry through his patent on IAP binding compounds highlight his role as a significant inventor. His work continues to influence therapeutic and diagnostic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile